Part 2/14:
The year 2020 marked an extraordinary era in medical science, driven by the urgent need to combat the COVID-19 pandemic. Researchers and pharmaceutical companies worldwide embarked on a race to develop effective vaccines in record time. One such effort involves a collaboration between actress therapeutics and Arcturus, resulting in a novel vaccine candidate named Lunar Cov19. Unlike traditional processes that span 10 to 15 years, scientists aimed to shrink this timeline to about a year, utilizing cutting-edge technologies and accelerated trials. Singapore, a focal point in this effort, was preparing to commence human clinical trials, emphasizing the critical importance of safety and efficacy for a novel vaccine never before tested in humans.